These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2068440)

  • 1. [Efficacy and tolerance of cyclosporin A in the treatment of multiple sclerosis].
    Schluep M; Steck AJ; Despland PA; Regli F; Ochsner F; Berrut E; Gauthier G
    Schweiz Rundsch Med Prax; 1991 Jun; 80(24):670-2. PubMed ID: 2068440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study.
    Kappos L; Patzold U; Dommasch D; Poser S; Haas J; Krauseneck P; Malin JP; Fierz W; Graffenried BU; Gugerli US
    Ann Neurol; 1988 Jan; 23(1):56-63. PubMed ID: 3278672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosuppressive therapy of multiple sclerosis using cyclosporin A and azathioprine. Long-term effects, risks, proton spin tomography and immunological findings].
    Kappos L
    Schriftenr Neurol; 1990; 32():1-200. PubMed ID: 2200108
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine versus azathioprine in the treatment of multiple sclerosis: 12-month clinical and immunological evaluation.
    Steck AJ; Regli F; Ochsner F; Gauthier G
    Eur Neurol; 1990; 30(4):224-8. PubMed ID: 2209678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clinical trial of cyclosporine in multiple sclerosis: the pros.
    Dommasch D
    Neurology; 1988 Jul; 38(7 Suppl 2):28-9. PubMed ID: 3290711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. The Multiple Sclerosis Study Group.
    Ann Neurol; 1990 Jun; 27(6):591-605. PubMed ID: 2193613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cyclosporin in autoimmune diseases].
    Frey FJ
    Schweiz Med Wochenschr; 1990 May; 120(21):772-86. PubMed ID: 2190313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
    Lhermitte F; Marteau R; Roullet E; de Saxcé H; Loridan M
    Rev Neurol (Paris); 1984; 140(10):553-8. PubMed ID: 6438761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of 213 cases of multiple sclerosis treated with azathioprine from 1967- to 1982].
    Aimard G; Confavreux C; Ventre JJ; Guillot M; Devic M
    Rev Neurol (Paris); 1983; 139(8-9):509-13. PubMed ID: 6648202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomised comparative study on the influence of cyclosporin and azathioprine on renal allograft survival and function.
    Henny FC; Kootte AM; Van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
    Nephrol Dial Transplant; 1986; 1(1):44-9. PubMed ID: 3110662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclosporine, azathioprine, and steroids on the renal transplant, on the cytologic patterns of intragraft inflammation, and on concomitant rejection-associated changes in recipient blood.
    Häyry P; von Willebrand E; Ahonen J; Eklund B; Salmela K; Höckerstedt K; Pettersson E; Koskimies S
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):153-62. PubMed ID: 3284065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of renal transplantation rejection. Cyclosporin A versus conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in primary cadaveric renal transplantation.
    Hall BM; Tiller DJ; Horvath JS; Duggin GG; Johnson JR; Roy LP; Hurley B; Harris JP; Rogers JR; Stephen MS
    Med J Aust; 1985 Feb; 142(3):179-85. PubMed ID: 3881654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
    Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P
    Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
    Frick E; Angstwurm H; Strauss G
    MMW Munch Med Wochenschr; 1974 Nov; 116(48):2105-12. PubMed ID: 4216823
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine and multiple sclerosis: the cons.
    Rudge P
    Neurology; 1988 Jul; 38(7 Suppl 2):29-30. PubMed ID: 3290712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with interferon beta-1b and azathioprine in secondary progressive multiple sclerosis. A two-year pilot study.
    Fernández O; Guerrero M; Mayorga C; Muñoz L; Leán A; Luque G; Hervás M; Fernández V; Capdevila A; de Ramón E
    J Neurol; 2002 Aug; 249(8):1058-62. PubMed ID: 12195454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term effects of glatiramer acetate in multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacterial infection complications in the early period after kidney transplantation: azathioprine vs cyclosporin A].
    Janda P; Prát V
    Cas Lek Cesk; 1987 Dec; 126(52):1617-9. PubMed ID: 3327588
    [No Abstract]   [Full Text] [Related]  

  • 19. [New proposals for the treatment of multiple sclerosis. Preliminary study].
    Floris V; Spadaro M
    Riv Neurol; 1985; 55(3):169-84. PubMed ID: 4035256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deterioration in glucose metabolism in pancreatic transplant recipients after conversion from azathioprine to cyclosporine.
    Gunnarsson R; Klintmalm G; Lundgren G; Tydén G; Wilczek H; Ostman J; Groth CG
    Transplant Proc; 1984 Jun; 16(3):709-12. PubMed ID: 6375038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.